Clinical Trials

50 enrolled

Small Cell Lung Carcinoma

NCT07609251 2026-05-27

A Clinical Study of SCTB41 Combined With Docetaxel in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer（Phase II Study Ongoing）

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07609472 2026-05-27

FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma

76 enrolled

CNS

Glioma

NCT07609823 2026-05-27

A Phase 2 Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL

LymphoidOther hematologic neoplasm

75 enrolled

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07287098 2026-05-22

preEMBER

600 enrolled

Breast Neoplasms

NCT07603791 2026-05-22

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.

252 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07486817 2026-05-19

Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab

Lung Neoplasms

NCT07597629 2026-05-19

A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer

114 enrolled

Advanced Breast Cancer

NCT07589569 2026-05-15

An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

92 enrolled

Pancreatic Neoplasms

NCT07589634 2026-05-15

TRI Pro

230 enrolled

Plasma cell

Multiple Myeloma

NCT07591090 2026-05-15

A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer

200 enrolled

Advanced Breast Cancer

NCT07586124 2026-05-14

Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma

80 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07586202 2026-05-14

AmiNA

68 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07578337 2026-05-13

NUMANTIA-2

40 enrolled

Neoplasms, Pancreatic Neoplasms

NCT07564466 2026-05-11

A Study of SKB571 in Participants With Gastrointestinal Tumors

120 enrolled

Digestive System Neoplasms

NCT07324629 2026-05-07

Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma

30 enrolled

Thymoma

NCT07569965 2026-05-06

FRONTIER

52 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT07565285 2026-05-04

INFLECTION-003

48 enrolled

Melanoma

NCT07560449 2026-05-01

QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms

162 enrolled

Plasma cell

Malignant Plasma Cell Neoplasms

NCT07562581 2026-05-01

A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC

48 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT07560111 2026-04-30

A Phase II Study of GC101 in NSCLC

28 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07554859 2026-04-28

GFH375 Monotherapy and Combination Therapy as First-Line Treatment for Advanced KRAS G12D-Mutant Non-Small Cell Lung Cancer

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07545044 2026-04-22

A Study of JSKN003 Versus Trastuzumab in Combination With Pertuzumab and Docetaxel as First-Line Treatment for HER2-Positive Recurrent or Metastatic Breast Cancer

Breast Neoplasms

NCT03301805 2026-04-20

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

40 enrolled

Pancreatic Neoplasms

NCT07533942 2026-04-16

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

30 enrolled

CNS

Meningioma

NCT07527858 2026-04-14

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

170 enrolled

Advanced Microsatellite Stable Colorectal Cancer

NCT07529405 2026-04-14

CurbMF

386 enrolled

Lymphoid

Mycosis Fungoides

NCT07522476 2026-04-13

A Clinical Study to Evaluate the Efficacy and Safety of VG2025 in Intrahepatic Cholangiocarcinoma

30 enrolled

Cholangiocarcinoma

NCT07513454 2026-04-07

A Phase 2 Study of HW211026 in Participants With Actinic Keratosis

80 enrolled

Keratosis, Actinic

NCT07494435 2026-03-27

Phase 2 Study of WGI-0301 Plus Nivolumab in Patients With HCC and RCC

230 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT07497074 2026-03-27

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

78 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04910386 2026-03-25

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

126 enrolled

Biliary Tract Neoplasms

NCT07492680 2026-03-25

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

CNSDermatologicGastrointestinal

260 enrolled

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

NCT07487519 2026-03-23

Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07489066 2026-03-23

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

120 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT06708455 2026-03-19

Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

65 enrolled

Melanoma

NCT07483554 2026-03-19

IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

389 enrolled

CLDN18.2 Positive

NCT07224672 2026-03-17

ALANIS

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

NCT07477366 2026-03-17

Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

20 enrolled

Lymphoid

Lymphoma, B-Cell

NCT07474727 2026-03-16

A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

Colorectal Neoplasms

NCT07452224 2026-03-12

ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07457164 2026-03-12

A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer

40 enrolled

Genitourinary

Urogenital Diseases, Prostatic Diseases

NCT07465757 2026-03-12

ALISCA-Lung2

50 enrolled

Small Cell Lung Carcinoma

NCT05265052 2026-03-11

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

177 enrolled

Cancer Pain

NCT07227350 2026-03-10

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Carcinoma, Basal Cell

NCT07459738 2026-03-10

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms

NCT07227870 2026-03-09

L19IL2/TNF in Patients With Basal Cell Carcinoma

92 enrolled

Carcinoma, Basal Cell

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT06075030 2026-02-27

A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy

36 enrolled

Classical hematology

Chemotherapy Induced Anemia

NCT06075043 2026-02-27

A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy